About Genosity
Genosity is a Healthcare company based in Iselin (United States) founded in 2016, and was acquired by Invitae in April 2021. Provider of technical support services for biopharma industry. Its focus areas include Biopharma Outsourcing and Software Development Services. Its competitors include Zephyr AI, Transaction Data Systems and OpenEye Scientific; 1 of its 3 listed competitors has raised funding.
Company details
Genosity, founded in 2016 in Iselin, United States, focuses on providing healthcare solutions, biopharma outsourcing, and software development services. Provider of technical support services for biopharma industry. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Iselin, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genosity.com
- Social LinkedIn
- Acquired by Invitae (Apr 2021)
Investors in Genosity
Genosity has secured backing from 1 investor. Prominent investors backing the company include Invitae.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for Genosity
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genosity
2 dated milestones of Genosity across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Genosity is founded.
- Exit Acquired by Invitae.
Competitors of Genosity
Genosity has 3 listed competitors in our database, 1 of them funded. They include Zephyr AI, Transaction Data Systems and OpenEye Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zephyrai.bio | 2020 | United States | $129.85M | Provider of AI development services for biopharma sector | ||
| tdsclinical.com | 1977 | Earth, United States | Software development services are provided to the biopharma sector. | |||
| eyesopen.com | 1997 | Santa Fe, United States | 101 | Drug discovery and design are enabled by a cloud-based platform. |
Detailed competitors of Genosity
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Genosity (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genosity
Complete news archive for Genosity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genosity
Genosity was founded in 2016.
Genosity is headquartered in Iselin, United States. It is registered at Iselin, New Jersey, United States.
Genosity, founded in 2016 in Iselin, United States, focuses on providing healthcare solutions, biopharma outsourcing, and software development services. Provider of technical support services for biopharma industry. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Genosity's top competitors include Zephyr AI, OpenEye Scientific and Transaction Data Systems.
Genosity has 1 investor. Key investors include Invitae.
Yes. Genosity was acquired by Invitae in April 2021.